Published in
Elsevier, Leukemia Research, (81), p. 82-87, 2019
DOI: 10.1016/j.leukres.2019.04.010
Links
Tools
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors
Journal article published in 2019 by
Laetitia Largeaud,
Emilie Bérard,
Sarah Bertoli,
Stéphanie Dufrechou,
Naïs Prade,
Noémie Gadaud,
Suzanne Tavitian,
Pierre Bories 
,
Isabelle Luquet,
Audrey Sarry,
Véronique De Mas,
Françoise Huguet,
Eric Delabesse,
Christian Récher
,
Isabelle Luquet,
Audrey Sarry,
Véronique De Mas,
Françoise Huguet,
Eric Delabesse,
Christian Récher
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 